Bao, Hua

Investigating novel resistance mechanisms to third-generation EGFR tyrosine kinase inhibitor osimertinib in non-small cell lung cancer patients

Yang, Z., Yang, N., Ou, Q., Xiang, Y., Jiang, T., Wu, X., Bao, H., Tong, X., Wang, X., Shao, Y. W., et al. (2018) · Clinical Cancer Research

Lung Cancer Treatments and MutationsHER2/EGFR in Cancer Research

Cited by 542

Early change of plasma Epstein-Barr virus DNA load and the viral lytic genome level could positively predict clinical outcome in recurrent or metastatic nasopharyngeal carcinoma receiving anti-programmed cell death 1 monotherapy

Lin, S., Zhou, H., Chen, G., Xue, J., Liu, Q., Li, J., Yang, Y., Zhao, Y., Bao, H., Huang, Y., et al. (2024) · BMC Cancer

Viral-associated cancers and disordersHead and Neck Cancer Studies

Cited by 10